171 related articles for article (PubMed ID: 37558503)
1. Cumulative Use of Proton Pump Inhibitors and Risk of Dementia: The Atherosclerosis Risk in Communities Study.
Northuis CA; Bell EJ; Lutsey PL; George KM; Gottesman RF; Mosley TH; Whitsel EA; Lakshminarayan K
Neurology; 2023 Oct; 101(18):e1771-e1778. PubMed ID: 37558503
[TBL] [Abstract][Full Text] [Related]
2. Associations Between Midlife Vascular Risk Factors and 25-Year Incident Dementia in the Atherosclerosis Risk in Communities (ARIC) Cohort.
Gottesman RF; Albert MS; Alonso A; Coker LH; Coresh J; Davis SM; Deal JA; McKhann GM; Mosley TH; Sharrett AR; Schneider ALC; Windham BG; Wruck LM; Knopman DS
JAMA Neurol; 2017 Oct; 74(10):1246-1254. PubMed ID: 28783817
[TBL] [Abstract][Full Text] [Related]
3. Time-Varying Use of Proton Pump Inhibitors and Cognitive Impairment and Dementia: A Real-World Analysis from Germany.
Ahn N; Wawro N; Baumeister SE; Nolde M; Gerlach R; Tauscher M; Günter A; Güntner F; Rückert-Eheberg IM; Meisinger C; Linseisen J
Drugs Aging; 2023 Jul; 40(7):653-663. PubMed ID: 37178361
[TBL] [Abstract][Full Text] [Related]
4. Proton Pump Inhibitor Use, Hypomagnesemia and Risk of Cardiovascular Diseases: The Atherosclerosis Risk in Communities (ARIC) Study.
Rooney MR; Bell EJ; Alonso A; Pankow JS; Demmer RT; Rudser KD; Chen LY; Lutsey PL
J Clin Gastroenterol; 2021 Sep; 55(8):677-683. PubMed ID: 33471493
[TBL] [Abstract][Full Text] [Related]
5. Proton pump inhibitors and dementia risk: Evidence from a cohort study using linked routinely collected national health data in Wales, UK.
Cooksey R; Kennedy J; Dennis MS; Escott-Price V; Lyons RA; Seaborne M; Brophy S
PLoS One; 2020; 15(9):e0237676. PubMed ID: 32946449
[TBL] [Abstract][Full Text] [Related]
6. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.
Lazarus B; Chen Y; Wilson FP; Sang Y; Chang AR; Coresh J; Grams ME
JAMA Intern Med; 2016 Feb; 176(2):238-46. PubMed ID: 26752337
[TBL] [Abstract][Full Text] [Related]
7. Risk of dementia from proton pump inhibitor use in Asian population: A nationwide cohort study in Taiwan.
Tai SY; Chien CY; Wu DC; Lin KD; Ho BL; Chang YH; Chang YP
PLoS One; 2017; 12(2):e0171006. PubMed ID: 28199356
[TBL] [Abstract][Full Text] [Related]
8. Association of Proton Pump Inhibitors With Risk of Dementia: A Pharmacoepidemiological Claims Data Analysis.
Gomm W; von Holt K; Thomé F; Broich K; Maier W; Fink A; Doblhammer G; Haenisch B
JAMA Neurol; 2016 Apr; 73(4):410-6. PubMed ID: 26882076
[TBL] [Abstract][Full Text] [Related]
9. Clinical Use of Acid Suppressants and Risk of Dementia in the Elderly: A Pharmaco-Epidemiological Cohort Study.
Chen LY; Lin HJ; Wu WT; Chen YC; Chen CL; Kao J; You SL; Chou YC; Sun CA
Int J Environ Res Public Health; 2020 Nov; 17(21):. PubMed ID: 33182362
[TBL] [Abstract][Full Text] [Related]
10. Proton Pump Inhibitor Use and Dementia Risk: Prospective Population-Based Study.
Gray SL; Walker RL; Dublin S; Yu O; Aiello Bowles EJ; Anderson ML; Crane PK; Larson EB
J Am Geriatr Soc; 2018 Feb; 66(2):247-253. PubMed ID: 29134629
[TBL] [Abstract][Full Text] [Related]
11. Lack of Association Between Proton Pump Inhibitor Use and Cognitive Decline.
Wod M; Hallas J; Andersen K; García Rodríguez LA; Christensen K; Gaist D
Clin Gastroenterol Hepatol; 2018 May; 16(5):681-689. PubMed ID: 29391266
[TBL] [Abstract][Full Text] [Related]
12. Association of Proton Pump Inhibitors With Higher Risk of Cardiovascular Disease and Heart Failure.
Bell EJ; Bielinski SJ; St Sauver JL; Chen LY; Rooney MR; Larson NB; Takahashi PY; Folsom AR
Mayo Clin Proc; 2021 Oct; 96(10):2540-2549. PubMed ID: 34607633
[TBL] [Abstract][Full Text] [Related]
13. Association Between Midlife Risk Factors and Late-Onset Epilepsy: Results From the Atherosclerosis Risk in Communities Study.
Johnson EL; Krauss GL; Lee AK; Schneider ALC; Dearborn JL; Kucharska-Newton AM; Huang J; Alonso A; Gottesman RF
JAMA Neurol; 2018 Nov; 75(11):1375-1382. PubMed ID: 30039175
[TBL] [Abstract][Full Text] [Related]
14. Emulating a target trial of proton pump inhibitors and dementia risk using claims data.
Ahn N; Nolde M; Günter A; Güntner F; Gerlach R; Tauscher M; Amann U; Linseisen J; Meisinger C; Rückert-Eheberg IM; Baumeister SE
Eur J Neurol; 2022 May; 29(5):1335-1343. PubMed ID: 35170158
[TBL] [Abstract][Full Text] [Related]
15. Association of Proton Pump Inhibitors Usage with Risk of Pneumonia in Dementia Patients.
Ho SW; Teng YH; Yang SF; Yeh HW; Wang YH; Chou MC; Yeh CB
J Am Geriatr Soc; 2017 Jul; 65(7):1441-1447. PubMed ID: 28321840
[TBL] [Abstract][Full Text] [Related]
16. Proton Pump Inhibitors and Risk of Acute and Chronic Kidney Disease: A Retrospective Cohort Study.
Hart E; Dunn TE; Feuerstein S; Jacobs DM
Pharmacotherapy; 2019 Apr; 39(4):443-453. PubMed ID: 30779194
[TBL] [Abstract][Full Text] [Related]
17. Proton pump inhibitors and dementia: A nationwide population-based study.
Pourhadi N; Janbek J; Jensen-Dahm C; Gasse C; Laursen TM; Waldemar G
Alzheimers Dement; 2024 Feb; 20(2):837-845. PubMed ID: 37795826
[TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibitors and risk for recurrent Clostridium difficile infection among inpatients.
Freedberg DE; Salmasian H; Friedman C; Abrams JA
Am J Gastroenterol; 2013 Nov; 108(11):1794-801. PubMed ID: 24060760
[TBL] [Abstract][Full Text] [Related]
19. Does Long-Term Proton Pump Inhibitor Use Increase Risk of Dementia? Not Really! Results of the Group-Based Trajectory Analysis.
Huang ST; Tseng LY; Chen LK; Peng LN; Hsiao FY
Clin Pharmacol Ther; 2019 Sep; 106(3):616-622. PubMed ID: 30861103
[TBL] [Abstract][Full Text] [Related]
20. Beyond uncertainty: Negative findings for the association between the use of proton pump inhibitors and risk of dementia.
Park SK; Nam JH; Lee H; Chung H; Lee EK; Shin JY
J Gastroenterol Hepatol; 2019 Dec; 34(12):2135-2143. PubMed ID: 31145825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
